Dr. Claxton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
500 University Dr
Hershey, PA 17033Phone+1 800-233-4082- Is this information wrong?
Summary
- I am Board Certified in Internal Medicine and Oncology. My practice is Malignant Hematology - particularly Leukemia. I have an active translational lab and conduct both clinical and laboratory research.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1987 - 1990
McGill University Faculty of MedicineClass of 1978
Certifications & Licensure
PA State Medical License 2000 - 2024
TX State Medical License 1990 - 2003- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly
- America's Top Doctors for Cancer Castle Connolly
Clinical Trials
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Start of enrollment: 2006 Aug 01
- Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients Start of enrollment: 2007 Dec 01
- Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods.Darren Brow, Jasmine Kendrick, Linnea Pettersson, Zhuo Li, Jennifer Tyler, Mohamed Elrefaei, Hiroko Shike, Shin Mineishi, David F Claxton, Baldeep Wirk, Joseph Cioccio...> ;Human Immunology. 2024 Mar 28
- Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes.B Bishal Paudel, Su-Fern Tan, Todd E Fox, Johnson Ung, Upendarrao Golla, Jeremy J P Shaw, Wendy Dunton, Irene Lee, Wisam A Fares, Satyam Patel, Arati Sharma, Aaron D V...> ;Blood Advances. 2024 Mar 12
- Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation: Comparison of Two Chimerism Test Strategies, Next-Generation Sequ...Aiwen Zhang, Stacey Macecevic, Dawn Thomas, Jeffrey Allen, Sarah Mandley, Paul Kawczak, Raymond Jurcago, Jennifer Tyler, Heather Casey, David Bosler, Ronald Sobecks, B...> ;The Journal of Molecular Diagnostics. 2024 Apr 1
- Join now to see all
Journal Articles
- Clofarabine Followed by Haploidentical Stem Cell Transplant Using Fludarabine, Busulfan, and Total-Body Irradiation with Post-Transplant Cyclophosphamide in Non-Remiss...Shin Mineishi, David Claxton, Kevin Rakszawski, Hiroko Shike, International Journal of Hematology
Abstracts/Posters
- Effect of Avelumab to Immune Response in AML: A Phase I Study of Avelumab in Combination with Decitabine As First Line Treatment of Unfit PatientsDavid F. Claxton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Resul...David F. Claxton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particular...David F. Claxton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Impact of Minimal Residual Disease and Achievement of Complete Remission/Complete Remission with Partial Hematologic Recovery (CR/CRh) on Overall Survival Following Tr...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Novel Small Molecule Inhibitor KS99 Targets AML and Inhibits Stemness Markers STAT3 and ALDH2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Multi-Dimensional Analysis of Immune Signature Predicts Response to Decitabine Treatment in Elderly Patients with AML2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Woman Shares Rock Solid HopeSeptember 28th, 2016
Grant Support
- Autologous Anti-Cml ImmunityNational Cancer Institute1998–2002
- Core Binding Factor In Leukemogenesis--Inv(16) And T(8;21)National Cancer Institute1996–2001
Professional Memberships
- Member
Other Languages
- French
Hospital Affiliations
Penn State Milton S. Hershey Medical CenterHershey, Pennsylvania
External Links
- Publicationshttp://www.ncbi.nlm.nih.gov/sites/myncbi/1-7ao0ZyMxnk6/bibliography/47971609/public/?sort=date&direction=ascending
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
